UPCOMING SESSIONS in ET
Thu, Jun 4, 2026
5:00 – 6:00 AM Bangkok
Cardiac Amyloidosis: New Strategies for Disease-Modifying Therapies Nitasha Sarswat Click To Register
UPCOMING SESSIONS in ET
Thu, Jun 4, 2026 · 5:00 – 6:00 AM Bangkok
Cardiac Amyloidosis: New Strategies for Disease-Modifying Therapies
Nitasha Sarswat
Click To Register
View all sessions

Apolipoprotein A-IV Cardiac Amyloidosis as a Diagnostic Pitfall: Beyond the Non-Invasive Algorithm

Source
Sciencedirect

Abstract

Background

Cardiac amyloidosis is frequently underdiagnosed and rarer forms (e.g., non-transthyretin or light chain amyloidosis) can be challenging to uncover.

Case summary

A 71-year-old male with reduced kidney function presented with new-onset heart failure, concentric left ventricular hypertrophy, and an "apical sparing" strain pattern. Cardiovascular magnetic resonance (CMR) confirmed an infiltrative phenotype with suggestive late gadolinium enhancement and parametric mapping pattern. However, bone scintigraphy and monoclonal protein screening were negative, and therefore, an endomyocardial biopsy was performed. After negative immunohistochemistry, mass spectrometry-based proteomics finally identified Apolipoprotein A-IV (ApoA-IV) amyloidosis.